Guillain-Barré syndrome
- PMID: 40693120
- PMCID: PMC12276597
- DOI: 10.1016/j.bjae.2025.05.001
Guillain-Barré syndrome
Keywords: Bickerstaff brainstem encephalitis; Guillain–Barré syndrome; Miller Fisher syndrome.
Conflict of interest statement
BCJ reports institutional funding for research related to GBS from Prinses Beatrix Spierfonds, Zon-MW, GBS-CIDP Foundation International, Horizon 2020, Grifols, CSL-Behring, Annexon, Roche and Hansa Biopharma. BJ is in the clinical trial committee of Annexon. BJ serves as the chair of the steering committee of IGOS and is a member of the Global Medical Advisory Board of the GBS-CIDP Foundation International. JH, EW and WE declare that they have no conflicts of interest.
References
-
- Willison H.J., Jacobs B.C., van Doorn P.A. Guillain-Barré syndrome. Lancet. 2016;388:717–727. - PubMed
-
- Fokke C., van den Berg B., Drenthen J., Walgaard C., van Doorn P.A., Jacobs B.C. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2013;137:33–43. - PubMed
-
- Luijten L.W.G., Doets A.Y., Arends S., et al. Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2023;94:300–308. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
